IPOGrid
0001839998
IPO filing research

American Oncology Network, Inc.

Services-Health Services

follow-on priced EFFECT

American Oncology Network, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2024-12-13.

Filing Timeline

SEC EDGAR
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2024-12-13 · 9999999995-24-003772
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-11-15 · 0001628280-24-048135
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-08-15 · 0001628280-24-037364
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-07-26 · 0001839998-24-000078
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-06-03 · 0001839998-24-000060
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-05-21 · 0001839998-24-000047
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2024-05-16 · 0001839998-24-000043
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2024-05-06 · 0001140361-24-024556
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-05-03 · 9999999995-24-001365
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-12-07 · 0001140361-23-056580
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2023-12-06 · 9999999995-23-003559
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2023-11-20 · 0001140361-23-053917
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2023-10-13 · 0001140361-23-048206
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2023-09-20 · 0001104659-23-102153
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 425 and confirms the priced prospectus.
2023-09-15 · 0001104659-23-101000
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-09-15 · 0001104659-23-100999
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-21 · 0001104659-23-093899
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-16 · 0001104659-23-092260
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2023-07-25 · 0001104659-23-083845
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-07-18 · 9999999995-23-002121
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-4/A and confirms the priced prospectus.
2023-07-18 · 0001104659-23-082047
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2023-07-14 · 0001104659-23-081125
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2023-07-13 · 0001104659-23-080423
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2023-06-29 · 0001104659-23-075910
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-06-27 · 0001104659-23-075243
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2023-06-15 · 0001104659-23-071330
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2023-06-15 · 0001104659-23-071329
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-06-07 · 0001104659-23-068892
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-05-02 · 0001104659-23-054723
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-05-01 · 0001104659-23-053242
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4 in the pre-IPO sequence.
2023-04-28 · 0001104659-23-051794
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B4 in the pre-IPO sequence.
2023-04-28 · 0001104659-23-051785
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2021-03-11 · 0001104659-21-035097
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2021-03-09 · 9999999995-21-000874
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2021-03-09 · 0001354457-21-000320
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2021-03-08 · 0001104659-21-033158
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2021-03-01 · 0001104659-21-029545
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2021-02-12 · 0001104659-21-022029
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2021-01-29 · 0001104659-21-009507
Comparable Deals

4 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 4 using nearest neighbors.
+20.1%
Median day-1
75%
Above issue
+45.5%
Median week-1
-21.2%
Downside (p10)
Lumexa Imaging Holdings, Inc. LMRI
2025-12-11 $435M Day 1: +0.1% Wk 1: -7.7%
same SIC grouprecent IPO
Park Dental Partners, Inc. PARK
2025-12-03 $20M Day 1: -21.2% Wk 1: +21.3%
same SIC grouprecent IPO
BillionToOne, Inc. BLLN
2025-11-06 $273M Day 1: +81.6% Wk 1: +69.7%
same SIC grouprecent IPO
Charming Medical Ltd MCTA
2025-10-21 $8M Day 1: +40.0% Wk 1: +93.4%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.